Gothenburg, Sweden: Mycorena today announced the opening of their new pilot production facility in Gamlestaden, Gothenburg. The new facility, dubbed MIND (Mycorena Innovation and Development Centre), marks the next steps in the fast-growing company’s journey to be the biggest Mycoprotein supplier in Europe by 2025. It is the first of its kind in Scandinavia. At an annual production capacity starting at 10 tonnes, it is one of the largest pilot- and test facilities to produce Mycoprotein in Europe.
“Despite all uncertainties of the pandemic, 2020 has been an incredible year for us, and the demand for our product, Promyc, has outgrown the capacity of our previous facility.” says Ramkumar Nair, founder and CEO at Mycorena. “We built MIND to upscale our production capacity to cater to the growing demand from our food industry partners for Promyc. It will also facilitate our continued research and innovation efforts towards strengthening our current IP portfolio.”
The move will enable Mycorena to increase its production capacity, which has seen an exponential increase in demand over the past year. As one of the few mycoprotein alternatives on the market, the company is a unique challenger in the competitive market for meat alternatives.
This news comes in the wake of many recent accomplishments of the company, including:
